EGFR and breast carcinoma: Deregulation of apoptosis is a hallmark of all cancer cells, and the agents that activate apoptosis in cancer cells could be valuable anticancer therapeutics; breast cancer cell lines that hyper express the EGFR have been documented to undergo receptor-mediated apoptosis.